Identification | More | [Name]
3-Fluorophenylhydrazine hydrochloride | [CAS]
2924-16-5 | [Synonyms]
1-(3-FLUOROPHENYL)HYDRAZINE HYDROCHLORIDE 3-FLUOROPHENYLHYDRAZINE HYDROCHLORIDE 3-FLUOROPHENYLHYDRAZINE HYDROCHLORIDE, 9 7% 3-Fluorophenylhydrazine HCl 3-Fluorophenylhydrazine hydrochloride 97% Hydrazine, (3-fluorophenyl)-, monohydrochloride | [EINECS(EC#)]
220-886-4 | [Molecular Formula]
C6H8ClFN2 | [MDL Number]
MFCD00012934 | [Molecular Weight]
162.59 | [MOL File]
2924-16-5.mol |
Chemical Properties | Back Directory | [Appearance]
white to light yellow crystal powde | [Melting point ]
268 °C (dec.)(lit.)
| [storage temp. ]
Inert atmosphere,2-8°C | [solubility ]
Chloroform : DMSO = 1 : 1 (Slightly), Methanol (Slightly) | [form ]
Powder | [color ]
White to light brown | [BRN ]
3627729 | [CAS DataBase Reference]
2924-16-5(CAS DataBase Reference) |
Safety Data | Back Directory | [Hazard Codes ]
Xn,Xi,T | [Risk Statements ]
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed . R36/37/38:Irritating to eyes, respiratory system and skin . R43:May cause sensitization by skin contact. R40:Limited evidence of a carcinogenic effect. R23/24/25:Toxic by inhalation, in contact with skin and if swallowed . | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice . S37/39:Wear suitable gloves and eye/face protection . S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) . S36/37:Wear suitable protective clothing and gloves . S36:Wear suitable protective clothing . | [RIDADR ]
2811 | [WGK Germany ]
3
| [Hazard Note ]
Irritant | [HazardClass ]
IRRITANT | [PackingGroup ]
III | [HS Code ]
29280000 |
Hazard Information | Back Directory | [Chemical Properties]
white to light yellow crystal powde | [Uses]
3-Fluorophenylhydrazine Hydrochloride can be used to synthesize compounds that are useful for the prophylaxis and treatment of pro-inflammatory cytokine mediated diseases, and in particular, p38 activity mediated inflammation and related conditions. |
|
|